The circulating metabolome in idiopathic pulmonary fibrosis (IPF)

被引：0
|
作者：
Hesslinger, Christian [1 ]
Overton, Robert [2 ]
Keller, Sascha [1 ]
Neely, Megan L. [2 ,3 ]
Belperio, John A. [4 ]
Vinisko, Richard [5 ]
Leonard, Thomas [5 ]
Flaherty, Kevin R. [6 ]
Noth, Imre [7 ]
Palmer, Scott M. [2 ,3 ]
Todd, Jamie L. [2 ,3 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[2] Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[5] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[6] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[7] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.0A1924
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating Prostasin: An Independent Risk Marker in Idiopathic Pulmonary Fibrosis (IPF)
    Todd, J. L.
    Page, C.
    Wu, P.
    Belperio, J. A.
    Maher, T. M.
    Palmer, S. M.
    Leonard, T. B.
    Hesslinger, C.
    Neely, M. L.
    Schlange, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [2] Circulating prostasin associates with presence and severity of idiopathic pulmonary fibrosis (IPF)
    Todd, Jamie
    Mulder, Hillary
    Neely, Megan L.
    Belperio, John A.
    Lasky, Joseph A.
    Luckhardt, Tracy R.
    Palmer, Scott M.
    Hesslinger, Christian
    Schlange, Thomas
    Leonard, Thomas B.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Idiopathic Pulmonary Fibrosis (IPF): An Overview
    Barratt, Shaney L.
    Creamer, Andrew
    Hayton, Conal
    Chaudhuri, Nazia
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (08)
  • [4] Sleep and idiopathic pulmonary fibrosis (IPF)
    Rasche, Kurt
    Leidag, Markus
    Orth, Maritta
    SOMNOLOGIE, 2020, 24 (01): : 11 - 15
  • [5] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
    FULMER, J
    ELSON, N
    GAL, EV
    MCLEES, B
    DEMETS, D
    WEINBERGER, S
    KELMAN, J
    CRYSTAL, R
    CLINICAL RESEARCH, 1978, 26 (03): : A538 - A538
  • [6] Outcomes of Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Patients with Circulating Autoantibodies
    Smith, A.
    Ding, G.
    Kropski, J.
    Mason, W.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Idiopathic pulmonary fibrosis (IPF) and gastroeosophageal disorders
    Kokeza, Josipa
    Mise, Kornelija
    Puljiz, Zeljko
    Bradaric, Anteo
    Lozo, Emilija
    Mise, Josko
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Idiopathic pulmonary fibrosis (IPF): the patient journey
    Cottin, Vincent
    Bonella, Francesco
    Small, Mark
    Siddall, James
    Langley, Jonathan
    Inoue, Yoshikazu
    Lancaster, Lisa
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    Ross Summer
    Jamie L. Todd
    Megan L. Neely
    L. Jason Lobo
    Andrew Namen
    L. Kristin Newby
    Shirin Shafazand
    Sally Suliman
    Christian Hesslinger
    Sascha Keller
    Thomas B. Leonard
    Scott M. Palmer
    Olga Ilkayeva
    Michael J. Muehlbauer
    Christopher B. Newgard
    Jesse Roman
    Respiratory Research, 25
  • [10] THE RESPIRATORY MICROBIOME AND METABOLOME IN IDIOPATHIC PULMONARY FIBROSIS
    Invernizzi, R.
    Giallourou, N.
    Swann, J. R.
    Hewitt, R. J.
    Ghai, P.
    Wu, B. G.
    Li, Y.
    Segal, L. N.
    Byrne, A. J.
    Maher, T. M.
    Lloyd, C. M.
    Molyneaux, P. L.
    THORAX, 2021, 76 : A2 - A3
12345